Table 2 Prognostic factors associated with the clinical cure rate 7–10 days after the end of treatment using a stepwise logistic model (ITT population).
| Parameter | Odds ratio | Probability | 95% Confidence interval | |
|---|---|---|---|---|
| Lower limit | Upper limit | |||
| Treatment (0 = comparator; 1 = moxifloxacin) | 1.485 | 0.015 | 1.079 | 2.044 |
| Cardiopulmonary disease (0 = no; 1 = yes) | 0.585 | 0.016 | 0.378 | 0.903 |
| FEV1 (%) at enrolment (0 = ⩾50; 1 = <50) | 0.482 | <0.001 | 0.349 | 0.666 |
| Number of AECBs in previous year (0 = 2–3; 1 = ⩾4) | 0.684 | 0.032 | 0.483 | 0.967 |
There was no interaction between treatment and any of the individual factors (cardiopulmonary, p = 0.241; FEV1, p = 0.452; number of AECBs in previous year, p = 0.547).